W44. Careers in Industry
Session: Premeeting Workshop: Fellows' Day Workshop ($)
Wednesday, October 3, 2018: 12:00 PM
Room: W 2006-2008
Elizabeth Hermsen, PharmD, MBA, BCPS (AQ-ID), FIDP, Global Population Health, Merck & Co., Inc., Kenilworth, NJ

Dr. Hermsen is the Head of Global Antimicrobial Stewardship at Merck & Co., Inc. and an Adjunct Associate Professor at the University of Nebraska Medical Center, Colleges of Pharmacy and Medicine, in Omaha, Nebraska. Dr. Hermsen received her Doctor of Pharmacy degree from the University of Nebraska Medical Center followed by a pharmacy practice residency at The Nebraska Medical Center, a fellowship in Infectious Diseases Research at the University of Minnesota, College of Pharmacy, and a master’s degree in business administration at the University of Minnesota, Carlson School of Management with an emphasis in healthcare industry. Following her fellowship, Dr. Hermsen developed and co-directed the antimicrobial stewardship program at The Nebraska Medical Center and subsequently joined Cubist, where she created and led the Antimicrobial Stewardship Outreach Group. Now, in her role at Merck, she is responsible for creating and executing a strategy to advance antimicrobial stewardship through education, implementation, research, and advocacy focused on patient outcomes, population health, and the value of care. She has a global scope that includes human health, animal health, and environmental sciences. When leading the program at The Nebraska Medical Center, Dr. Hermsen developed a publicly-available antimicrobial stewardship website (www.nebraskamed.com/asp) that subsequently was featured in an article regarding top web resources for antimicrobial stewardship (Pagani L, et al. Navigating the Web in Search of Resources on Antimicrobial Stewardship in Health Care Institutions. Clin Infect Dis. 2009; 48:626-32.). Dr. Hermsen actively contributed to the advancement of the Society of Infectious Diseases Pharmacists (SIDP) Antimicrobial Stewardship Certificate Program during her term as SIDP President and continues to participate as a lecturer in the program. Dr. Hermsen served as a contributing member of the Antimicrobial Stewardship Knowledge & Skills Collaborative, coordinated by the Society for Healthcare Epidemiology of America; an expert panel on Antimicrobial Practice Improvement in Hospitals, coordinated by the American Society of Health-System Pharmacists; an expert panel on Hospital-based Antimicrobial Utilization Surveillance via the National Healthcare Safety Network, coordinated by the Centers for Disease Control and Prevention; the Cardinal Health Infectious Diseases Advisory Group; an expert panel coordinated by the National Quality Forum and CDC to develop the practical tool entitled, Antibiotic Stewardship in Acute Care: A Practical Playbook (http://www.qualityforum.org/Publications/2016/05/National_Quality_Partners_Playbook__Antibiotic_Stewardship_in_Acute_Care.aspx); and co-chaired the Antimicrobial Stewardship Work Package (1A) for the Innovative Medicines Institute (IMI) Driving Reinvestment in Research & Development and Responsible Antibiotic Use (DRIVE-AB) initiative (www.drive-ab.eu). Dr. Hermsen currently serves as a member of the Forum on Microbial Threats for the National Academies of Sciences, Engineering, and Medicine (NASEM) and is a member of the Industry Advisory Group for the One Health Platform. Dr. Hermsen is a Board Certified Pharmacotherapy Specialist with added qualifications in Infectious Diseases and is a Fellow of SIDP. She has contributed to the profession with numerous publications in peer-reviewed journals, book contributions, and by serving as a reviewer for several professional journals. Dr. Hermsen has also given over 100 invited presentations at state, regional, national, and international meetings.


E. Hermsen, Merck: Employee and Shareholder , Salary and Shares of stock .

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.